Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset analysis of the open-label TAUSSIG study-Reference-Cited by-同舟云学术

Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset analysis of the open-label TAUSSIG study

Published:2017-04 Issue:4 Volume:5 Page:280-290
ISSN:2213-8587
Container-title:The Lancet Diabetes & Endocrinology
language:en
Short-container-title:The Lancet Diabetes & Endocrinology

Author:

Raal Frederick J,Hovingh G Kees,Blom Dirk,Santos Raul D,Harada-Shiba Mariko,Bruckert Eric,Couture Patrick,Soran Handrean,Watts Gerald F,Kurtz Christopher,Honarpour Narimon,Tang Lihua,Kasichayanula Sree,Wasserman Scott M,Stein Evan A

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference28 articles.

1. Low-density lipoprotein receptor gene familial hypercholesterolemia variant database: update and pathological assessment;Usifo;Ann Hum Genet,2012

2. Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype-phenotype relationship, and clinical outcome;Sjouke;Eur Heart J,2015

3. Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society;Cuchel;Eur Heart J,2014

4. Homozygous familial hypercholesterolemia: current perspectives on diagnosis and treatment;Raal;Atherosclerosis,2012

5. A dose-titration and comparative study of rosuvastatin and atorvastatin in patients with homozygous familial hypercholesterolaemia;Marais;Atherosclerosis,2008

Cited by 199 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The multifaceted role of PCSK9 in cancer pathogenesis, tumor immunity, and immunotherapy;Medical Oncology;2024-07-15

2. Evolocumab Treatment in Pediatric Patients With Homozygous Familial Hypercholesterolemia: Pooled Data From Three Open-Label Studies;Arteriosclerosis, Thrombosis, and Vascular Biology;2024-05

3. Current treatments for the management of homozygous familial hypercholesterolaemia: a systematic review and commentary;European Journal of Preventive Cardiology;2024-04-18

4. Proprotein convertase subtilisin/kexin type 9-inhibition across different patient populations;Current Opinion in Lipidology;2024-03-27

5. Current and emerging monoclonal antibodies for treating familial hypercholesterolemia in children;Expert Opinion on Biological Therapy;2024-03-21